NO20084478L - Konjugerte lipidderivater - Google Patents
Konjugerte lipidderivaterInfo
- Publication number
- NO20084478L NO20084478L NO20084478A NO20084478A NO20084478L NO 20084478 L NO20084478 L NO 20084478L NO 20084478 A NO20084478 A NO 20084478A NO 20084478 A NO20084478 A NO 20084478A NO 20084478 L NO20084478 L NO 20084478L
- Authority
- NO
- Norway
- Prior art keywords
- lipid derivatives
- conjugated lipid
- compounds
- unsaturated fatty
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0605900.0A GB0605900D0 (en) | 2006-03-23 | 2006-03-23 | Modulators of nuclear receptors |
| PCT/IB2007/000731 WO2007107869A2 (en) | 2006-03-23 | 2007-03-23 | Lipid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20084478L true NO20084478L (no) | 2008-10-23 |
Family
ID=36384087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20084478A NO20084478L (no) | 2006-03-23 | 2008-10-23 | Konjugerte lipidderivater |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8178708B2 (pt) |
| EP (1) | EP2007702A2 (pt) |
| JP (1) | JP2009530366A (pt) |
| KR (1) | KR20080105095A (pt) |
| CN (1) | CN101410362B (pt) |
| BR (1) | BRPI0708981A2 (pt) |
| CA (1) | CA2647020A1 (pt) |
| GB (1) | GB0605900D0 (pt) |
| MX (1) | MX2008012089A (pt) |
| NO (1) | NO20084478L (pt) |
| RU (1) | RU2480447C2 (pt) |
| WO (1) | WO2007107869A2 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5337479B2 (ja) | 2005-05-04 | 2013-11-06 | プロノヴァ・バイオファーマ・ノルゲ・アーエス | 新規化合物 |
| GB0605900D0 (en) | 2006-03-23 | 2006-05-03 | Lipigen As | Modulators of nuclear receptors |
| CA2667150A1 (en) * | 2006-11-01 | 2008-11-06 | Pronova Biopharma Norge As | Omega-3 lipid compounds |
| WO2008053331A1 (en) | 2006-11-01 | 2008-05-08 | Pronova Biopharma Norge A/S | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| DE102007051339A1 (de) * | 2007-10-26 | 2009-04-30 | Müller-Enoch, Dieter, Prof. Dr. | Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien |
| WO2009134147A1 (en) * | 2008-05-02 | 2009-11-05 | Pronova Biopharma Norge As | Lipid compositions containing derivatives of epa and dha an their use thereof |
| WO2009149496A1 (en) * | 2008-06-10 | 2009-12-17 | Central Northern Adelaide Health Service | Treatment of diabetes and complications thereof and related disorders |
| JP2013538215A (ja) | 2010-08-31 | 2013-10-10 | エスエヌユー アールアンドディービー ファウンデーション | ＰＰＡＲδアゴニストの胎児再プログラミング用途 |
| AU2013222179B2 (en) * | 2012-02-24 | 2017-08-24 | Arbutus Biopharma Corporat ion | Trialkyl cationic lipids and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE178287C (pt) * | ||||
| DE178298C (pt) | ||||
| NL296925A (pt) * | 1900-01-01 | |||
| GB549933A (en) * | 1940-07-11 | 1942-12-15 | Hoffmann La Roche | Process for the manufacture of í¸-phytadienic acid |
| US4264517A (en) * | 1978-12-11 | 1981-04-28 | G.D. Searle & Co. | Alkylphenyl 5Z,8Z,11Z,14Z,17Z-eicosapentaenoates |
| GB2218904A (en) * | 1988-05-27 | 1989-11-29 | Renafield Limited | Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid |
| US5407816A (en) * | 1992-02-20 | 1995-04-18 | Phyton Catalytic, Inc. | Enhanced production of taxol and taxanes by cell cultures of taxus species |
| AU5928898A (en) * | 1997-01-24 | 1998-08-18 | Regents Of The University Of California, The | Use of fxr, pparalpha and lxralpha activators to restore barrier function, promote epidermal differentiation and inhibit proliferation |
| WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
| US6586461B1 (en) * | 1998-06-16 | 2003-07-01 | Wayne State University | Prenyl transferase inhibitors |
| WO2001007047A2 (en) * | 1999-07-23 | 2001-02-01 | Bioparken As | Control of crustacean infestation of aquatic animals |
| ITMI20020960A1 (it) | 2002-05-07 | 2003-11-07 | Univ Degli Studi Milano | Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale |
| US7981915B2 (en) * | 2003-04-30 | 2011-07-19 | Beth Israel Deaconess Medical Center | Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene |
| DE10322635A1 (de) * | 2003-05-20 | 2004-12-23 | Symrise Gmbh & Co. Kg | Verwendung von alpha-Terpenen als Riechstoffe |
| GB0605900D0 (en) | 2006-03-23 | 2006-05-03 | Lipigen As | Modulators of nuclear receptors |
-
2006
- 2006-03-23 GB GBGB0605900.0A patent/GB0605900D0/en not_active Ceased
-
2007
- 2007-03-23 BR BRPI0708981-3A patent/BRPI0708981A2/pt not_active IP Right Cessation
- 2007-03-23 KR KR1020087022994A patent/KR20080105095A/ko not_active Application Discontinuation
- 2007-03-23 JP JP2009500957A patent/JP2009530366A/ja active Pending
- 2007-03-23 MX MX2008012089A patent/MX2008012089A/es active IP Right Grant
- 2007-03-23 CA CA002647020A patent/CA2647020A1/en not_active Abandoned
- 2007-03-23 EP EP07734062A patent/EP2007702A2/en not_active Withdrawn
- 2007-03-23 CN CN2007800104009A patent/CN101410362B/zh not_active Expired - Fee Related
- 2007-03-23 RU RU2008141907/04A patent/RU2480447C2/ru not_active IP Right Cessation
- 2007-03-23 WO PCT/IB2007/000731 patent/WO2007107869A2/en active Application Filing
- 2007-03-23 US US12/293,966 patent/US8178708B2/en not_active Expired - Fee Related
-
2008
- 2008-10-23 NO NO20084478A patent/NO20084478L/no not_active Application Discontinuation
-
2012
- 2012-03-15 US US13/420,874 patent/US20120232143A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120232143A1 (en) | 2012-09-13 |
| CA2647020A1 (en) | 2007-09-27 |
| BRPI0708981A2 (pt) | 2011-06-21 |
| GB0605900D0 (en) | 2006-05-03 |
| KR20080105095A (ko) | 2008-12-03 |
| US20090105499A1 (en) | 2009-04-23 |
| RU2008141907A (ru) | 2010-04-27 |
| JP2009530366A (ja) | 2009-08-27 |
| CN101410362B (zh) | 2013-07-10 |
| CN101410362A (zh) | 2009-04-15 |
| WO2007107869A3 (en) | 2007-12-06 |
| US8178708B2 (en) | 2012-05-15 |
| EP2007702A2 (en) | 2008-12-31 |
| RU2480447C2 (ru) | 2013-04-27 |
| MX2008012089A (es) | 2008-10-07 |
| WO2007107869A2 (en) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084478L (no) | Konjugerte lipidderivater | |
| MX2011012122A (es) | Derivados de tiofeno. | |
| UY30438A1 (es) | Derivados n-sustituidos de 5-halo-4-[2-alquil-1-sustituidos-1h-imidazol-5-il]pirimidin-2-amina, composiciones-procesos para su preparacion y usos | |
| DOP2011000264A (es) | Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia | |
| CY1112831T1 (el) | Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh | |
| UY31046A1 (es) | Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones | |
| ATE452120T1 (de) | Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür | |
| UA94395C2 (ru) | Производное изоксазолина и способ его получения | |
| BRPI0620229B8 (pt) | formulações farmaceuticas e processos de produção da ditas formulações | |
| EA201490653A1 (ru) | Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств | |
| NO20083905L (no) | Nye pyron-indol derivater og fremgangsmate for deres fremstilling | |
| ATE485261T1 (de) | Salicylsäurederivate | |
| EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
| BRPI0408848B8 (pt) | composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação | |
| MX2009012713A (es) | Nuevos derivados de acido 3-fenil acrilico de receptores de tipo ppar, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas. | |
| GT200800235A (es) | Formulacion de medicamento liquida | |
| ATE454889T1 (de) | Arzneimittel zur behandlung von sarkoglykanopathien | |
| UY30126A1 (es) | Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones | |
| EA200801137A1 (ru) | Соединения для ингибирования апоптоза | |
| MX2009012841A (es) | Nuevos derivados del acido 3-fenil propanoico que son activadores de los receptores del tipo del receptor activado por el proliferador de peroxisoma, su metodo de preparacion y su uso en composiciones cosmeticas o farmaceuticas. | |
| RU2011143735A (ru) | Средство для отбеливания кожи и косметический способ отбеливания кожи | |
| CY1107277T1 (el) | Βενζισοξαζολες | |
| EA200870567A1 (ru) | Производные 2-алкокси-3,4,5-тригидроксиалкиламида, их получение, композиции, их содержащие, и применение | |
| UY29550A1 (es) | Derivados de (sulfamoil-alquil)-amida de ácido heteroaril-carboxílico como inhibidores del factor xa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |